|
product
|
|
|
Product name
|
Formula
|
Formula weight
|
CAS RN
|
|
A-01
|
Dolasetron mesylate monohydrate
|
C19H20N2O3·CH4O3S· H2O
|
438.50
|
115956-13-3
|
|
A-02
|
Fenoldopam Mesylate
|
C16H16ClNO3·CH4O3S
|
401.87
|
67227-57-0
|
|
A-03
|
Tiotropium Bromide
|
C19H22BrNO4S2·H2O
|
490.44
|
139404-48-1
|
|
A-04
|
Fluvoxamine maleate
|
C15H21F3N2O2·C4H4O4
|
434.4
|
61718-82-9
|
|
A-05
|
Palonosetron Hydrochloride
|
C19H24N2O·HCl
|
332.87
|
119904-90-4
|
|
A-06
|
Sarpogrelate Hydrochloride
|
C24H31NO6・HCl
|
466.02
|
135159-51-2
|
|
A-07
|
Epalrestat
|
C15H13NO3S2
|
319.39
|
82159-09-9
|
|
A-08
|
Topiramate and intermediate
|
|
|
97240-79-4
|
|
A-09
|
Repaglinide
|
|
|
135062-02-1
|
|
|
|
Intermediate
|
|
|
Product name
|
Formula
|
Formula weight
|
CAS RN
|
|
IM-01
|
(3-(methoxycarbonyl)-7-hydroxy-9-Azabicyclo[3.3.1]nonane-9-acetic acid methyl ester（Dolasetron intermediate）
|
C13H21NO5
|
271.32
|
125483-28-5
|
|
IM-02
|
5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone (MECO) (Fluvoxamine Intermediate)
|
C13H15F3O2
|
260.25
|
61718-80-7
|
|
IM-03
|
N-[2-Hydroxy-2(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine（Fenoldopam intermediate）
|
C19H24NO4Cl
|
365.85
|
71636-38-9
|
|
IM-04
|
3-Aminoquinuclidine dihydrochloride (palonosetrion
intermediate)
|
C7H14N2·2HCl
|
199.12
|
6520-09-2
|
|
IM-05
|
(S)-3-Aminoquinuclidine dihydrochloride
|
C7H14N2·2HCl
|
199.12
|
119904-90-4
|
|
IM-06
|
(R)-3-Aminoquinuclidine dihydrochloride
|
C7H14N2·2HCl
|
199.12
|
123536-14-1
|
|
IM-07
|
1,2-Benisoxazole-3-acetica
acid (zonisamide intermediate)
|
C9H7NO3
|
177.16
|
|
|
IM-08
|
1,2-Benisoxazole-3-methane
sodium sulphonate (zonisamide intermediate)
|
C8H6NSO4Na
|
235.1
|
|
|
IM-09
|
(Z)-2-(tert-Methoxycarbonyl Methoxyimino)-2-(2-Aminothiazol-4-yl)Acetic
Acid (MICA ，NICA;cefixime
intermediate)
|
C8H9N3O5S
|
259.23
|
80554-17-8
|
|
IM-10
|
4-Chloro-2-(Z)-Methoxycarbonyl Methoxyimino-3-oxobutyric acid
(CMOBA; cefixime intermediate)
|
C7H8NO6Cl
|
229.5
|
84080-70-6
|
